Archive

As deadline looms, Mylan pushes Perrigo shareholders to OK buyout offer | TribLIVE.com
Local Stories

As deadline looms, Mylan pushes Perrigo shareholders to OK buyout offer

With a deadline looming, generic drugmaker Mylan NV appealed Tuesday to Perrigo Co. shareholders to accept a $30 billion buyout offer.

Mylan executives warned Perrigo shareholders that they aren’t going to find a better deal from another suitor. Chief Financial Officer John Sheehan said no other company has proposed a higher price.

“They simply will not be able to beat our offer,” he said on a conference call with analysts. “The silence is deafening.”

Mylan said the purpose of the call was to present its reasons Perrigo shareholders should support the deal. Shareholders of the Ireland-based generics company have until the end of day on Nov. 12 to decide if they should sell their shares to Mylan, which is headquartered in the Netherlands and run from Cecil.

Perrigo’s board has rejected several offers from Mylan since April, saying that the bids undervalued the company. Mylan started a hostile takeover last month, telling Perrigo shareholders it would buy them out for $75 and 2.3 Mylan shares. The offer values Perrigo at $173 a share.

Perrigo closed Tuesday at $158.18, down $3.35. Mylan closed at $41.42, down $1.48.

Mylan needs to buy more than 50 percent of Perrigo’s shares to take control of the maker of store-brand, over-the-counter medicines. If Mylan fails to meet that threshold, Irish law requires the company to drop its bid.

Once Mylan has control of the company, it plans to reopen the offer and hopes to convince remaining shareholders to sell. If it obtains 80 percent of Perrigo’s shares, remaining holdouts can be forced to sell their shares to Mylan under Irish law.

Perrigo officials could not be reached for comment Tuesday. Perrigo CEO Joseph Papa has criticized Mylan management and corporate governance and said the company “undervalues our compelling prospects for continued growth and sustainable, long-term shareholder value.”

Executive Chairman Robert Coury, who has traded barbs with Papa in recent months, said Mylan is offering a better deal than Perrigo’s management team can deliver as a standalone company.

“The strategic logic of this transaction remains undisputed,” he said. “This is simply the right next transaction for both companies.”

Coury declined to say how many Perrigo shares it has picked up, but said, “we have a lot of inquiries right now.”

Alex Nixon is a Trib Total Media staff writer. Reach him at 412-320-7928 or [email protected].


TribLIVE commenting policy

You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.